Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Fair Remedy Or Illegal Penalty? FDA Disgorgement Authority Questioned

Sep 29 2003

• By The Pink Sheet

Related Content

Schering Clarinex Onset Of Action Studies Do Not Support Claim, FDA Finds

Apr 08 2002

Wyeth Will Lose 18.5% Of Marietta Sales If Firm Does Not Comply With GMPs

Oct 09 2000

FDA Plays Up Police Role; “White Paper” Recaps Recent Enforcement Steps

Jul 07 2003

Compliance Officers Make Good “Whistleblowers” – U.S. Prosecutor Sheehan

Sep 29 2003

Schering Claritin, Rebetol Await FDA Certification After Consent Decree

May 20 2002

Schering Clarinex Approval Comes In Time For Big Spring Push

Dec 24 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window